Amoxicillin Industry Research Report 2025

Summary

Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.

According to APO Research, the global Amoxicillin market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Amoxicillin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Amoxicillin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Amoxicillin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Amoxicillin include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories and Sun Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amoxicillin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amoxicillin.

The report will help the Amoxicillin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Amoxicillin market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amoxicillin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Amoxicillin Segment by Company

GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Amoxicillin Segment by Type

Capsule
Tablet
Others
Amoxicillin Segment by Application

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Amoxicillin Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amoxicillin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amoxicillin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amoxicillin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amoxicillin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amoxicillin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amoxicillin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Amoxicillin Market Size (2020-2031)
2.2.2 Global Amoxicillin Sales (2020-2031)
2.2.3 Global Amoxicillin Market Average Price (2020-2031)
2.3 Amoxicillin by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Capsule
2.3.3 Tablet
2.3.4 Others
2.4 Amoxicillin by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital Pharmacy
2.4.3 Retail Pharmacy
2.4.4 Online Pharmacy
3 Market Competitive Landscape by Manufacturers
3.1 Global Amoxicillin Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Amoxicillin Sales (M Units) of Manufacturers (2020-2025)
3.3 Global Amoxicillin Revenue of Manufacturers (2020-2025)
3.4 Global Amoxicillin Average Price by Manufacturers (2020-2025)
3.5 Global Amoxicillin Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Amoxicillin, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Amoxicillin, Product Type & Application
3.8 Global Manufacturers of Amoxicillin, Established Date
3.9 Global Amoxicillin Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 GSK
4.1.1 GSK Company Information
4.1.2 GSK Business Overview
4.1.3 GSK Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.1.4 GSK Amoxicillin Product Portfolio
4.1.5 GSK Recent Developments
4.2 Novartis
4.2.1 Novartis Company Information
4.2.2 Novartis Business Overview
4.2.3 Novartis Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Novartis Amoxicillin Product Portfolio
4.2.5 Novartis Recent Developments
4.3 Centrient Pharma
4.3.1 Centrient Pharma Company Information
4.3.2 Centrient Pharma Business Overview
4.3.3 Centrient Pharma Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Centrient Pharma Amoxicillin Product Portfolio
4.3.5 Centrient Pharma Recent Developments
4.4 Teva
4.4.1 Teva Company Information
4.4.2 Teva Business Overview
4.4.3 Teva Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Teva Amoxicillin Product Portfolio
4.4.5 Teva Recent Developments
4.5 Mylan
4.5.1 Mylan Company Information
4.5.2 Mylan Business Overview
4.5.3 Mylan Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Mylan Amoxicillin Product Portfolio
4.5.5 Mylan Recent Developments
4.6 Cipla
4.6.1 Cipla Company Information
4.6.2 Cipla Business Overview
4.6.3 Cipla Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Cipla Amoxicillin Product Portfolio
4.6.5 Cipla Recent Developments
4.7 NCPC
4.7.1 NCPC Company Information
4.7.2 NCPC Business Overview
4.7.3 NCPC Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.7.4 NCPC Amoxicillin Product Portfolio
4.7.5 NCPC Recent Developments
4.8 United Laboratories
4.8.1 United Laboratories Company Information
4.8.2 United Laboratories Business Overview
4.8.3 United Laboratories Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.8.4 United Laboratories Amoxicillin Product Portfolio
4.8.5 United Laboratories Recent Developments
4.9 Sun Pharma
4.9.1 Sun Pharma Company Information
4.9.2 Sun Pharma Business Overview
4.9.3 Sun Pharma Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Sun Pharma Amoxicillin Product Portfolio
4.9.5 Sun Pharma Recent Developments
4.10 CSPC
4.10.1 CSPC Company Information
4.10.2 CSPC Business Overview
4.10.3 CSPC Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.10.4 CSPC Amoxicillin Product Portfolio
4.10.5 CSPC Recent Developments
4.11 LKPC
4.11.1 LKPC Company Information
4.11.2 LKPC Business Overview
4.11.3 LKPC Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.11.4 LKPC Amoxicillin Product Portfolio
4.11.5 LKPC Recent Developments
4.12 Hikma
4.12.1 Hikma Company Information
4.12.2 Hikma Business Overview
4.12.3 Hikma Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Hikma Amoxicillin Product Portfolio
4.12.5 Hikma Recent Developments
4.13 Dr. Reddy
4.13.1 Dr. Reddy Company Information
4.13.2 Dr. Reddy Business Overview
4.13.3 Dr. Reddy Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Dr. Reddy Amoxicillin Product Portfolio
4.13.5 Dr. Reddy Recent Developments
4.14 HPGC
4.14.1 HPGC Company Information
4.14.2 HPGC Business Overview
4.14.3 HPGC Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.14.4 HPGC Amoxicillin Product Portfolio
4.14.5 HPGC Recent Developments
4.15 Aurubindo
4.15.1 Aurubindo Company Information
4.15.2 Aurubindo Business Overview
4.15.3 Aurubindo Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Aurubindo Amoxicillin Product Portfolio
4.15.5 Aurubindo Recent Developments
4.16 Meiji Holdings
4.16.1 Meiji Holdings Company Information
4.16.2 Meiji Holdings Business Overview
4.16.3 Meiji Holdings Amoxicillin Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Meiji Holdings Amoxicillin Product Portfolio
4.16.5 Meiji Holdings Recent Developments
5 Global Amoxicillin Market Scenario by Region
5.1 Global Amoxicillin Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Amoxicillin Sales by Region: 2020-2031
5.2.1 Global Amoxicillin Sales by Region: 2020-2025
5.2.2 Global Amoxicillin Sales by Region: 2026-2031
5.3 Global Amoxicillin Revenue by Region: 2020-2031
5.3.1 Global Amoxicillin Revenue by Region: 2020-2025
5.3.2 Global Amoxicillin Revenue by Region: 2026-2031
5.4 North America Amoxicillin Market Facts & Figures by Country
5.4.1 North America Amoxicillin Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Amoxicillin Sales by Country (2020-2031)
5.4.3 North America Amoxicillin Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Amoxicillin Market Facts & Figures by Country
5.5.1 Europe Amoxicillin Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Amoxicillin Sales by Country (2020-2031)
5.5.3 Europe Amoxicillin Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Amoxicillin Market Facts & Figures by Country
5.6.1 Asia Pacific Amoxicillin Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Amoxicillin Sales by Country (2020-2031)
5.6.3 Asia Pacific Amoxicillin Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Amoxicillin Market Facts & Figures by Country
5.7.1 South America Amoxicillin Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Amoxicillin Sales by Country (2020-2031)
5.7.3 South America Amoxicillin Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Amoxicillin Market Facts & Figures by Country
5.8.1 Middle East and Africa Amoxicillin Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Amoxicillin Sales by Country (2020-2031)
5.8.3 Middle East and Africa Amoxicillin Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Amoxicillin Sales by Type (2020-2031)
6.1.1 Global Amoxicillin Sales by Type (2020-2031) & (M Units)
6.1.2 Global Amoxicillin Sales Market Share by Type (2020-2031)
6.2 Global Amoxicillin Revenue by Type (2020-2031)
6.2.1 Global Amoxicillin Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Amoxicillin Revenue Market Share by Type (2020-2031)
6.3 Global Amoxicillin Price by Type (2020-2031)
7 Segment by Application
7.1 Global Amoxicillin Sales by Application (2020-2031)
7.1.1 Global Amoxicillin Sales by Application (2020-2031) & (M Units)
7.1.2 Global Amoxicillin Sales Market Share by Application (2020-2031)
7.2 Global Amoxicillin Revenue by Application (2020-2031)
7.2.1 Global Amoxicillin Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Amoxicillin Revenue Market Share by Application (2020-2031)
7.3 Global Amoxicillin Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Amoxicillin Value Chain Analysis
8.1.1 Amoxicillin Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Amoxicillin Production Mode & Process
8.2 Amoxicillin Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Amoxicillin Distributors
8.2.3 Amoxicillin Customers
9 Global Amoxicillin Analyzing Market Dynamics
9.1 Amoxicillin Industry Trends
9.2 Amoxicillin Industry Drivers
9.3 Amoxicillin Industry Opportunities and Challenges
9.4 Amoxicillin Industry Restraints
10 Report Conclusion
11 Disclaimer

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings